Abirateron Zentiva 500 mg filmom obložene tablete
| Name | Abirateron Zentiva 500 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-598941461 |
| Active Substance | abirateronacetat |
| Composition | svaka tableta sadrži 500 mg abirateronacetata |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 56 tableta u blisteru, u kutiji [HR-H-598941461-01] 60 tableta u blisteru, u kutiji [HR-H-598941461-02] 56 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-598941461-03] 60 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-598941461-04] 60 tableta u bočici, u kutiji [HR-H-598941461-05] |
| Manufacturer | Synthon BV, Nijmegen, Nizozemska
Synthon Hispania S.L., Barcelona, Španjolska |
| Marketing Authorisation Holder | Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
| Marketing Authorisation Date | 01.04.2021 |
| MA Period of Validity | 01.04.2026 |
| Classification Number | UP/I-530-09/19-01/188 |
| Registration Number | 381-12-01/38-21-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02BX03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
